Pharmacists tackle research challenges at NIH

Young, Donna
June 2006
American Journal of Health-System Pharmacy;6/15/2006, Vol. 63 Issue 12, p1110
Academic Journal
The article reports on the challenges faced by pharmacists in conducting drug research at the National Institutes of Health Clinical Center in Bethesda, Maryland. Several challenges are confronted by pharmacists following their execution of drug experimentation that aims to benefit patients in the future. Furthermore, the implementation of advanced pharmacy computer system is one of the major obstacles being presented to the pharmacists.


Related Articles

  • INDIAN SUPERCOMPUTING CENTER BUYS FIRST SGI ALTIX 3000.  // UNIX Update;Jun2003, Vol. 14 Issue 6, p7 

    Focuses on the SGI Altix 3000 computer system acquired by the Supercomputing Education Research Centre, an institute for high-performance computing at the Indian Institute of Science in Bangalore, India.

  • Alliance to begin drug research in new lab by fall. Begin, Sherri // Crain's Detroit Business;4/10/2006, Vol. 22 Issue 15, p23 

    The article reports that the Life Sciences Core Technology Alliance, a consortium that includes Michigan's three largest research universities, plans by early fall to begin drug research at a new $18 million facility at Argonne National Labs in Lemont, Illinois, a federal lab operated by the...

  • Rx value vs. cost focus of diverse organizations. Conlan, Michael F. // Drug Topics;6/19/2000, Vol. 144 Issue 12, p90 

    Discusses the recommendations of RxHealthValue coalition to establish independent research institutes to study and release data on the comparative value of competing prescription drugs. Coalition members; Call of the coalition for the inclusion of information on the risks and benefits of...

  • Modeling Seismic faults.  // R&D Magazine;May98, Vol. 40 Issue 6, p79 

    Evaluates 3DStress, the interactive software system developed by researchers at Southwest Research Institute, in San Antonio, Texas. Functions of the software; Types of environmental problems which can be identified by the software; Contact number for further information.

  • Role of the pharmacist in preventing distribution of counterfeit medications. Chambliss, Walter G.; Carroll, Wesley A.; Kennedy, Daniel; Levine, Donald; MonĂ©, Michael A.; Ried, L. Douglas; Shepherd, Marv; Yelvigi, Mukund // Journal of the American Pharmacists Association: JAPhA;Mar/Apr2012, Vol. 52 Issue 2, p195 

    Objective: To provide an overview of the counterfeit medication problem and recommendations of a joint American Pharmacists Association (APhA) Academy of Pharmaceutical Research and Science and APhA Academy of Pharmacy Practice and Management taskforce. Date sources: SciFinder and PubMed were...

  • APhA2004 Abstracts of Contributed Papers.  // Journal of the American Pharmacists Association: JAPhA;Mar/Apr2004, Vol. 44 Issue 2, p226 

    Provides abstracts of original research papers presented at the American Pharmacists Association 2004 conference in Seattle, Washington. "Business Model for a Self-Sustaining Pharmacy Program in a Community Health Center," by J. Stubbings, S. Talsania Patel and A. Assam; "Analysis of the...

  • VARI Launches Drug Discovery Program. Emrich, Anne Bond // Grand Rapids Business Journal;4/19/2004, Vol. 22 Issue 16, p1 

    Reports that the Van Andel Research Institute (VARI) in Grand Rapids, Michigan has received a research grant from the U.S. National Institute of Health for a drug discovery program. Information on the Laboratory of Cell Structure and Cell Integration of VARI; Goals of the drug discovery...

  • Florida Chapter Learns About Scripps Florida. Frenz, Jamie // AMWA Journal: American Medical Writers Association Journal;2007, Vol. 22 Issue 2, p99 

    The article reports on the decision of the Scripps Research Institute to open of a research facility in Palm Beach County, Florida. Harry Orf, chemistry professor and vice president for scientific operations of the facility, notes that it will focus on biomedical science and drug discovery. It...

  • Novartis Creates Biomedical R & D Center in Shanghai.  // China Chemical Reporter;12/1/2006, Vol. 17 Issue 34, p10 

    The article reports that the pharmaceutical company Novartis AG is planning to build an integrated biomedical Research and Development center in Zhangjiang Hi-Tech Park, Shanghai, China. The plan is a commitment by Novartis to conduct cutting-edge pharmaceutical research and development in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics